back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-02-03 16:16 Tx date 2025-01-31 |
$DTC
Defence Therapeutics Inc. |
Meterissian, Sarkis
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
250,000 | |
| Filed 2023-12-22 17:06 Tx date 2023-12-21 |
$DTC
Defence Therapeutics Inc. |
Meterissian, Sarkis
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$125,000
+100,000 vol $1.25 each |
192,000 | |
| Filed 2023-12-22 17:05 Tx date 2023-12-21 |
$DTC
Defence Therapeutics Inc. |
Meterissian, Sarkis
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-100,000 vol |
200,000 | |
| Filed 2023-12-15 15:02 Tx date 2023-12-13 |
$DTC
Defence Therapeutics Inc. |
Meterissian, Sarkis
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$85,000
+68,000 vol $1.25 each |
92,000 | |
| Filed 2023-12-15 15:01 Tx date 2023-12-13 |
$DTC
Defence Therapeutics Inc. |
Meterissian, Sarkis
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-68,000 vol |
300,000 | |
| Filed 2023-12-13 14:43 Tx date 2023-12-08 |
$DTC
Defence Therapeutics Inc. |
Meterissian, Sarkis
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,500
-6,000 vol $2.75 each |
24,000 | |
| Filed 2023-11-24 14:23 Tx date 2023-11-20 |
$DTC
Defence Therapeutics Inc. |
Meterissian, Sarkis
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,340
-2,000 vol $2.67 each |
30,000 | |
| Filed 2023-11-15 15:12 Tx date 2023-11-15 |
$DTC
Defence Therapeutics Inc. |
Meterissian, Sarkis
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$40,000
+32,000 vol $1.25 each |
32,000 | |
| Filed 2023-11-15 15:12 Tx date 2021-04-30 |
$DTC
Defence Therapeutics Inc. |
Meterissian, Sarkis
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-11-15 15:11 Tx date 2023-11-15 |
$DTC
Defence Therapeutics Inc. |
Meterissian, Sarkis
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-32,000 vol |
368,000 | |
| Filed 2023-10-11 19:05 Tx date 2023-10-06 |
$DTC
Defence Therapeutics Inc. |
Meterissian, Sarkis
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
400,000 | |
| Filed 2021-05-03 17:07 Tx date 2021-04-30 |
$
Defence Therapeutics Inc. |
Meterissian, Sarkis
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 |